Proteinases in bone resorption: Obvious and less obvious roles

Clinica Chimica Acta

Volumn 291, Issue 2, 2000, Pages 223-234

  Delaissé, Jean Marie ^a   Engsig, Michael T ^a   Everts, Vincent ^b   Del Carmen Ovejero, Maria ^a   Ferreras, Mercedes ^a   Lund, Leif ^c   Vu, Thiennu H ^d   Werb, Zena ^d   Winding, Bent ^a   Lochter, André ^a   Karsdal, Morten A ^a   Troen, Tine ^a   Kirkegaard, Tove ^a   Lenhard, Thomas ^a   Heegaard, Anne Marie ^a   Neff, Lynn ^e   Baron, Roland ^e   Foged, Niels T ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c FINSEN LABORATORY   (Denmark)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone resorption; Cathepsin K; Collagenase; Matrix metalloproteinase (MMP); MMP 9; Osteoblast; Osteoclast

Indexed keywords

CATHEPSIN K; COLLAGENASE; GELATINASE B; MATRIX METALLOPROTEINASE; PROTEINASE;

ANIMAL CELL; BONE MATRIX; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW;

ANIMALIA;

EID: 0034651625     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00230-2     Document Type: Article

References (97)

1. Vaes G. Cellular biology and biochemical mechanism of bone resorption: A review of recent developments on the formation, activation, and mode of action of osteoclasts. Clin Ortop Rel Res. 231:1988;239-271.
2. Delaisse J.M., Vaes G. Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorption. Rifikin B.R., Gay C.V., Biology and physiology of the osteoclast. 1992;289-314 CRC Press, Boca Raton.
3. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 91:1997;439-442.
4. Delaisse J.M., Eeckhout Y., Vaes G. Inhibition of bone resorption in culture by inhibitors of thiol proteinases. Biochem J. 192:1980;365-368.
5. Delaisse J.M., Eeckhout Y., Vaes G. In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem Biophys Res Commun. 125:1984;441-447.
6. Delaisse J.M., Eeckhout Y., Sear C., Galloway A., McCullagh K., Vaes G. A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in culture. Biochem Biophys Res Commun. 133:1985;483-490.
7. Hill P.A., Murphy G., Docherty A.J., Hembry R.M., Millican T.A., Reynolds J.J., Meikle M.C. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci. 107:1994;3055-3064.
8. Hill P.A., Buttle D.J., Jones S.J., Boyde A., Murata M., Reynolds J.J., Meikle M.C. Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem. 56:1994;118-130.
9. 3H-tetracycline retention in bones of prelabelled mice. Bone. 12:1991;289.
10. Kusano K., Miyaura C., Inada M., Tamura T., Ito A., Nagase H., Kamoi K., Suda T. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology. 139:1998;1338-1345.
11. Everts V., Beertsen W., Schröder R. Effects of the proteinase inhbibitors leupeptin and E-64 on osteoclastic bone resorption. Calcif Tissue Int. 43:1988;172-178.
12. Everts V., Delaisse J.M., Korper W., Niehof A., Vaes G., Beertsen W. Degradation of collagen in the bone resorbing compartment underlying the osteoclast involves both cysteine proteinases and matrix metalloproteinases. J Cell Physiol. 150:1992;221-231.
13. Everts V., Delaisse J.M., Korper W., Beertsen W. Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J Bone Min Res. 13:1998;1420-1430.
14. Everts V., Korper W., Jansen D.C., Steinfort J., Lammerse I., Heera S., Docherty A.J., Beertsen W. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J. 13:1999;1219-1230.
15. Okada Y., Naka K., Kawamura K., Matsumoto T., Nakanishi I., Fujimoto N., Sato H., Seiki M. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase=gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest. 72:1995;311-322.
16. Delaisse J.M., Eeckhout Y., Neff L., Francois-Gillet C., Henriet P., Su Y., Vaes G., Baron R. (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J Cell Sci. 106:1993;1071-1082.
17. Tezuka K., Nemoto K., Tezuka Y., Sato T., Ikeda Y., Kobori M., Kawashima H., Eguchi H., Hakeda Y., Kumegawa M. Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem. 269:1994;15006-15009.
18. Reponen P., Sahlberg C., Munaut C., Thesleff I., Tryggvason K. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol. 124:1994;1091-1102.
19. Wucherpfennig A.L., Li Y.P., Stetler-Stevenson W.G., Rosenberg A.E., Stashenko P. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts. J Bone Miner Res. 9:1994;549-556.
20. Chen Q.J., Lund L., Lenhard T., Engsig M., Winding B., Therkildsen B., Pedersen A.C., Larsen D., Werb Z., Foged N.T., Delaisse J.M. MMP-9 is a regulator of osteoclast recruitment as demonstrated by targeted mutagenesis. Bone. 23:1998;S548.
21. Tezuka K., Tezuka Y., Maejima A., Sato T., Nemoto K., Kamioka H., Hakeda Y., Kumegawa M. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem. 269:1994;1106-1109.
22. Rantakokko J., Aro H.T., Savontaus M., Vuorio E. Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett. 393:1996;307-313.
23. Inaoka T., Bilbe G., Ishibashi O., Tezuka K., Kumegawa M., Kokubo T. Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun. 206:1995;89-96.
24. Drake F.H., Dodds R.A., James I.E., Connor J.R., Debouck C., Richardson S., Lee-Rykaczewski E., Coleman L., Rieman D., Barthlow R., Hastings G., Gowen M. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem. 271:1996;12511-12516.
25. Littlewood-Evans A., Kokubo T., Ishibashi O., Inaoka T., Wlodarski B., Gallagher J.A., Bilbe G. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone. 20:1997;81-86.
26. Saneshige S., Mano H., Tezuka K., Kakudo S., Mori Y., Honda Y., Itabashi A., Yamada T., Miyata K., Hakeda Y. Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC-2. Biochem J. 309:1995;721-724.
27. Kakudo S., Mano H., Shiokawa M., Mori Y., Kumegawa M., Hakeda Y. Concanavalin A directly stimulates bone-resorbing activity of osteoclasts and their gene expression of cathepsin K/OC-2. Biochem Biophys Res Commun. 234:1997;600-604.
28. Kamiya T., Kobayashi Y., Kanaoka K., Nakashima T., Kato Y., Mizuno A., Sakai H. Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts. J Biochem. 123:1999;752-759.
29. Gelb B.D., Shi G.P., Chapman H.A., Desnick R.J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 273:1996;1236-1238.
30. Hou W.S., Bromme D., Zhao Y., Mehler E., Dushey C., Weinstein H., Miranda C.S., Fraga C., Greig F., Carey J., Rimoin D.L., Desnick R.J., Gelb B.D. Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest. 103:1999;731-738.
31. Saftig P., Hunziker E., Wehmeyer O., Jones S., Boyde A., Rommerskirch W., Detlev Moritz J., Schu P., Von Figura K. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin K deficient mice. Proc Natl Acad Sci. 95:1998;13453-13458.
32. Dodds R.A., Cristiano F., Field J., Kapadia R., Liang X., Debouck C., Kola I., Gowen M. Cathepsin K knockout mice develop osteopetrosis due to lack of full function in their osteoclasts. Bone. 23:1998;S164.
33. Everts V., Saftig P., Korper W., Delaissé J.M., Bromme D., Beertsen W. Cathepsin K is more essential for long bone resorption than resorption of calvarial bone. J Bone Miner Res. 14:1999;S356.
34. Inui T., Ishibashi O., Inaoka T., Origane Y., Kumegawa M., Kokubo T., Yamamura T. Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem. 272:1997;8109-8112.
35. Everts V., Aronson D.C., Beertsen W. Phagocytosis of bone collagen by osteoclasts in two cases of Pycnodysostosis. Calcif Tissue Int. 37:1985;25-31.
36. Garnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S., Foged N.T., Delmas P.D., Delaisse J.M. The collagenolytic activity of cathepsin K is unique amongst mammalian proteinases. J Biol Chem. 273:1998;32347-32352.
37. Brömme D., Okamoto K., Wang B.B., Biroc S. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem. 271:1996;2126-2132.
38. Blavier L., Delaisse J.M. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci. 108:1995;3649-3659.
39. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., Shapiro S.D., Senior R.M., Werb Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocyres. Cell. 96:1998;411-422.
40. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., Wagner E.F. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodelling. Science. 266:1994;443-448.
41. Jemtland R., Lee K., Segre G.V. Hetrogeneity among cells that express osteoclast-associated genes in developing bones. Endocrinology. 139:1998;340-349.
42. Rice D.P.C., Kim H.J., Thesleff I. Detection of geletinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development. Bone. 21:1997;479-486.
43. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 5:1999;623-628.
44. Lee E.R., Murphy G., El-Alfi M., Davoli M.A., Lamplugh L., Docherty A.J., Leblond C.P. Qactive gelatinase B is identified by histozymography in the cartilage resorption sites of developing long bones. Dev Dyn. 215:1999;190-205.
45. Sato T., Ovejero M.C., Hou P., Heegaard A.M., Kumegawa M., Foged N.T., Delaisse J.M. Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J Cell Sci. 110:1997;589-596.
46. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:1994;61-65.
47. Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S.A., Mankani M., Robey P.G., Poole R., Pidoux I., Ward J.M., Birkedal-Hansen H. MT1-MMP deficiency develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 99:1999;81-92.
48. Rodan G.A., Martin T.J. Role of osteoblasts in hormonal control of bone resorptiona hypothesis. Calcif Tissue Int. 33:1981;349-351.
49. Chambers T.J. Regulation of osteoclast development and function. Rifkin B.R., Gay C.V., Biology and physiology of the osteoclast. 1992;105-128 CRC Press, Boca Raton.
50. Suda T., Udagawa N., Takahashi N. Cells of bone: osteoclast generation. Bilezikian J.P., Raisz L.G., Rodan G.A., Principles in bone biology. 1996;87-102 Academic Press, San Diego.
51. Corral D.A., Amling M., Priemel M., Loyer E., Fuchs S., Ducy P., Baron R., Karsenty G. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc Natl Acad Sci USA. 95:1998;13835-13840.
52. Otsuka K., Sodek J., Limeback H. Synthesis of collagenase and collgenase inhibitors by osteoblast-like cells in culture. Eur J Biochem. 145:1984;123-129.
53. Partridge N.C., Jeffrey J.J., Ehlich L.S., Teitelbaum S.L., Fliszar C., Welgus H.G., Kahn A.J. Hormonal regulation of the production of collagenase and a collagenase inhibitor activity by rat osteogenic sarcoma cells. Endocrinology. 120:1987;1956-1962.
54. Meikle M.C., Bord S., Hembry R.M., Compston J., Croucher P.I., Reynolds J.J. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. J Cell Sci. 103:1992;1093-1099.
55. Rifas L., Fausto A., Scott M.J., Avioli L.V., Welgus H.G. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis. Endocrinology. 134:1994;213-221.
56. Zhao W., Byrne M.H., Boyce B.F., Krane S.M. Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J Clin Invest. 103:1999;517-524.
57. Gack S., Vallon R., Schmidt J., Grigoriadis A., Tuckermann J., Schenkel J., Weiher H., Wagner E F., Angel P. Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth Differ. 6:1995;759-767.
58. Fuller K., Chambers T.J. Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J Cell Sci. 108:1995;2221-2230.
59. Stahle-Backdähl M., Sandstedt B., Bruce K., Lindahl A., Jiménez M.G., Vega J.A., López-Otín C. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and rheumatoid arthritis. Lab Invest. 76:1997;717-728.
60. Delaisse J.M., Eeckhout Y., Vaes G. Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. Endocrinology. 123:1988;264-276.
61. Imai K., Hiramatsu A., Fukushima D., Pierschbacher M.D., Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J. 322:1997;809-814.
62. D'Angelo M., Billings P.C., Pacifici M. Activation of hypertrophic chondrocytes in serum-free alginate culture. J Bone Min Res. 12:1997;S303.
63. Chambers T.J., Fuller K. Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J Cell Sci. 76:1985;155-165.
64. Holliday L.S., Welgus H.G., Fliszar C.J., Veith G.M., Jeffrey J.J., Gluck S.L. Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem. 272:1997;22053-22058.
65. Zhao W., Krane S. Increased bone formation accompanies resistance to collagenase cleavage of type I collagen. Bone. 23:1998;S236.
66. Karsdal M.A., Foged N.T., Delaissé J.M., Lochter A. THF-b1-induced osteoblast elongation regulates osteoclastic bone resorption: involvement of p39 MAP kinase and matrix metalloprotienases. J Bone Miner Res. 14:1999;S426.
67. Everts V., Delaissé J.M., Saftig P., Korper W., Beertsen W. Cathepsin K deficiency, collagen degradation, and coupling of bone resorption and formation. J Bone Miner Res. 14:1999;S357.
68. Votta B.J., Levy M.A., Badger A., Bradbeer J., Dodds R.A., James I.E., Thompson S., Bossard M.J., Carr T., Connor J.R., Tomaszek T.A., Szewczuk L., Drake F.H., Veber D.F., Gowen M. Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res. 12:1997;1396-1406.
69. Thompson S.K., Halbert S.M., Bossard M.J., Tomaszek T.A., Levy M.A., Zhao B., Smith W.W., Abdel-Meguid S.S., Janson C.A., D'Alessio K.J., McQueney M.S., Amegadzie B.Y., Hanning C.R., DesJarlais R.L., Briand J., Sarkar S.K., Huddleston M.J., Ijames C.F., Carr S.A., Garnes K.T., Shu A., Heys J.R., Bradbeer J., Zembryki D., Veber D.F. Design of potent and selective human cathepsin K inhibitors that span the active site. Proc Natl Acad Sci USA. 94:1997;14249-14254.
70. Mano H., Yuasa T., Kameda T., Miyazawa K., Nakamaru Y., Shiokawa M., Mori Y., Yamada T., Miyata K., Shindo H., Azuma H., Hakeda Y., Kumegawa M. Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun. 223:1996;637-642.
71. Ohnishi K., fujita N., Morinaga Y., Tsuruo T. H-31 human breast cancer cells stimulate type I collagenase production in osteoblast-like cells and induce bone resorption. Clin Exp Metastasis. 13:1995;287-295.
72. Kawashima A., Okada Y., Nakanishi I., Ueda Y., Iwata K., Roessner A. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. Gen Diagn Pathol. 142:1997;129-137.
73. Stearns M.E., Wang M. Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice. Clin Exp Metastasis. 16:1998;693-702.
74. Himelstein B.P., Asada N., Carlton M.R., Collins M.H. Matrix metalloproteinase (MMP-9) expression in childhood osseous osteosarcoma. Med Pediatr Oncol. 31:1998;471-474.
75. Sasaguri Y., Komiya S., Sugama K., Suzuki K., Inoue A., Morimatsu M., Nagase H. Production of matrix metalloproteinase 2 and 3 (stromelysin) by stromal cells and giant cell tumor of bone. Am J Pathol. 141:1992;611-621.
76. Ueda Y., Imai K., Tsuchiya H., Fujimoto N., Nakanishi I., Katsuda S., Seiki M., Okada Y. Matrix metaolloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am J Pathol. 148:1996;611-622.
77. Schoedel K.E., Greco M.A., Stetler-Stevenson W.G., Ohori N.P., Goswami S., Present D., Steiner G.C. Expression of metalloproteinases in giant cell tumor of bone: an immunohistochemical study with clinical correlation. Human Pathol. 27:1996;1144-1148.
78. Imai K., Ohta S., Matsumoto T., Fujimoto N., Sato H., Seiki M., Okada Y. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol. 151:1997;245-256.
79. Ohta S., Imai K., Yamashita K., Matsumoto T., Azumano I., Okada Y. Expression of matrix metalloproteinase 7 (Matrilysin) in human osteoarthritc cartilage. Lab Invest. 78:1998;79-87.
80. Tanaka S., Hamanishi C., Kikuchi H., Fukuda K. Factors related to degradation of articular cartilage in osteoarthritis: a review. Semi Arthritis Rheum. 27:1998;392-399.
81. Ishiguro N., Ito T., Ito H., Iwata H., Jugessur H., Ionescu M., Poole A.R. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Arrthritis Rheum. 41:1999;129-136.
82. Imai S., Konttinen Y.T., Jumppanen M., Lindy O., Ceponis A., Kemppinen P., Sorsa T., Santavirta S., Xu J.W., Lopez-Otin C. High levels of expression of collagenase-3 (MMP-13) in pathological conditions associated with a foreign-body reaction. J Bone Joint Surg Br. 80:1998;701-710.
83. Takagi M., Santavirta S., Ida H., Ishii M., Akimoto K., Saotome K., Konttinen Y.T. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses. Lab Invest. 78:1998;735-742.
84. Pap T., Pap G., Hummel K.M., Franz J.K., Jeisy E., Sainsbury I., Gay R.E., Billingham M., Neumann W., Gay S. Membrane-type I matrix metalloproteinase is abundantly expressed in fibroblasts and osteoclasts at the bone-implant interface of aseptically loosened joint arthroplasties in situ. J Rheumatol. 26:1999;166-169.
85. Nawrocki B., Polette M., Burlet H., Birembaut P., Adnet J.J. Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene. J Bone Min Res. 14:1999;288-294.
86. Takei I., Takagi M., Santavirta S., Ida H., Hamasaki M., Ishii M., Fukushima S., Ogino T., Konttinen Y.T. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints. J Biomed Mater Res. 45:1999;175-183.
87. Yamagiwa H., Tokunaga K., Hayami T., Hatano H., Uchida M., Endo N., Takahashi H.E. Expression of matrix metalloproteinase-13 (collagenase-3) messenger RNA during fracture healing. J Bone Min Res. 12:1997;S430.
88. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol. 64:1993;474-484.
89. Ingman T., Sorsa T., Lindy O., Koski H., Konttinen Y.T. Multiple forms of gelatinases/type IV collagenases in saliva and gingival crevicular fluid of periodontitis patients. J Clin Periodontol. 21:1994;26-31.
90. Yoneda T., Sasaki A., Dunstan C., Williams P.J., Bauss F., De Clerck Y.A., Mundy G.R. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest. 99:1997;2509-2517.
91. Winding B., Overgaard T., Holst-Hansen C., Foged N.T., Brunner N. Batimastat suppresses secondary tumor growth of human breast cancer in bone in nude mice through decreased osteoclastic activity. Bone. 23:1998;S377.
92. Campbell J.A., Van Wart H., Caulfield J.P., Eugie E., Womble S., Martin R., Browner M., Walker K., Fisher L., Brandl M., Castelhano A., Broka C., Hendicks R.T. Discovery of RS-130830, a potent and selective MMP inhibitor for osteoarthritis. Keystone Symposia. Metalloproteases: chemistry, biology and medicine. Tamarron, Colorado. February 25-March 3, 1999.
93. Ryan M.E., Ramamurthy S., Golub L.M. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Periodontol. 3:1996;85-96.
94. Golub L.M., Lee H.M., Ryan M.E., Giannobile W.V., Payne J., Sorsa T. Tetracyclines inhbit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res. 12:1998;12-26.
95. Nordstrom D., Lindy O., Lauhio A., Sorsa T., Santavirta S., Konttinen Y.T. Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumatol Int. 17:1998;175-180.
96. Williams S., Wakisaka A., Zeng Q.Q., Barnes J., Martin G., Wechter W.J., Liang C.T. Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats. Bone. 19:1996;637-644.
97. De Bri E., Lei W., Svensson O., Chowdhury M., Moak S.A., Greenwald R.A. Effect of an inhibitor of matrix metalloproteinases on spontaneous osteoarthritis in guinea pigs. Adv Dent Res. 12:1998;82-85.